Arena Pharmaceuticals Inc.
|
 | ||||||||||
|
 |
  |
 |
|
|
||
 |
 |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
 
 |
return to message board, top of board |
Re: Another Thought Bernie:
Do you understand what a CRL is?
Do you understand why the CRL policy was adopted a few years ago?
Do you understand why the ARNA worked to respond to the CRL letter?
Yes, there is a different between "new chemical entities" and
Yes, there is a difference between new classes of drugs and "look-alikes".
but if you do not understand these FDA policies, perhaps you are at far greater risk than you think!
Cheers
S_I
|
|||||||||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 18433 | Re: Another Thought | bbildman | 3/30/2012 11:32:31 AM | |
